Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Abstract Index</title></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmc">3990374</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990374</idno><idno type="RBID">PMC:3990374</idno><idno type="doi">10.1097/01.qai.0000446751.50448.49</idno><idno type="pmid">NONE</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">000249</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Abstract Index</title></analytic><series><title level="j">Journal of Acquired Immune Deficiency Syndromes (1999)</title><idno type="ISSN">1525-4135</idno><idno type="eISSN">1944-7884</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><pmc article-type="abstract"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Acquir Immune Defic Syndr</journal-id><journal-id journal-id-type="iso-abbrev">J. Acquir. Immune Defic. Syndr</journal-id><journal-id journal-id-type="publisher-id">qai</journal-id><journal-title-group><journal-title>Journal of Acquired Immune Deficiency Syndromes (1999)</journal-title></journal-title-group><issn pub-type="ppub">1525-4135</issn><issn pub-type="epub">1944-7884</issn><publisher><publisher-name>JAIDS Journal of Acquired Immune Deficiency Syndromes</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3990374</article-id><article-id pub-id-type="doi">10.1097/01.qai.0000446751.50448.49</article-id><article-id pub-id-type="art-access-id">00004</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract Index</subject></subj-group></article-categories><title-group><article-title>Abstract Index</article-title></title-group><pub-date pub-type="ppub"><month>4</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>07</day><month>3</month><year>2014</year></pub-date><volume>65</volume><issue>Suppl 2</issue><issue-title>15th Annual International Meeting of the Institute of Human Virology</issue-title><fpage>32</fpage><lpage>38</lpage><permissions><copyright-statement>Copyright © 2014 by Lippincott Williams & Wilkins</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivitives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.</license-p></license></permissions><self-uri xlink:type="simple" xlink:href="qai-65-32.pdf"></self-uri></article-meta></front><body><p>101 <italic>Biomedical Prevention of HIV/AIDS in Russia</italic></p><p>E. V. Karamov, R. M. Khaitov</p><p>National Research Centre Institute of Immunology, FMBA of Russia</p><p>102 <italic>HIV/AIDS Vaccines in Russia: Clinical Trials and Estimation of Acceptance in Population</italic></p><p>G. O. Gudima</p><p>National Research Centre Institute of Immunology, FMBA of Russia</p><p>103 <italic>Genetic Factors Defining Resistance and Susceptibility to HIV/AIDS</italic></p><p>I. A. Kofiadi</p><p>National Research Centre Institute of Immunology, FMBA of Russia</p><p>104 <italic>Cell-to-cell Transmission of HIV-1: Role of Virological Synapse</italic></p><p>A. V. Filatov, D. V. Mazurov</p><p>National Research Centre Institute of Immunology, FMBA of Russia</p><p>105 <italic>Rationale for HIV/AIDS Vaccines Design</italic></p><p>I. A. Nikolaeva</p><p>National Research Centre Institute of Immunology, FMBA of Russia</p><p>106 <italic>Enhance Expression of Transgene in Adenovirus</italic></p><p>R. I. Ataullakhanov</p><p>National Research Centre Institute of Immunology, FMBA of Russia</p><p>107 <italic>The Modern Methods of HIV/AIDS Vaccine Evaluation</italic></p><p>S. V. Korobova</p><p>National Research Centre Institute of Immunology, FMBA of Russia</p><p>108 <italic>Development of Universal Vaccines against Flu</italic></p><p>M. M. Shmarov</p><p>Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Health Ministry of the Russian Federation (Russia)</p><p>109 <italic>Genetically Engineered Tuberculosis Subunit Vaccine</italic></p><p>A. V. Tkachuk</p><p>Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Health Ministry of the Russian Federation (Russia)</p><p>110 <italic>Broadly Neutralizing Antibodies for Serotherapy and Vaccine Design</italic></p><p>Antonio Lanzavecchia, MD</p><p>Director of the Institute for Research in Biomedicine (Switzerland)</p><p>111 <italic>Update on Dengue Vaccines</italic></p><p>Alexander Schmidt, MD</p><p>Director, Clinical Research and Translational Science, GlaxoSmithKline Biologicals (US)</p><p>112 <italic>Development of Enterovirus 71 Vaccine</italic></p><p>Li Xiuling<xref ref-type="fn" rid="fn1">*</xref></p><p>National Vaccine and Serum Institute (China)</p><p>113 <italic>Epidemics of Acute Gastroenteritis Caused by Viruses and Vaccine Development in China</italic></p><p>Shen Shuo, PhD<xref ref-type="fn" rid="fn1">*</xref></p><p>Wuhan Institute of Biological Product (China)</p><p>114 <italic>Virus-Like Particles and Particle Vaccines</italic></p><p>Luigi Buonaguro, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>Ist. Naz.Tumori “Fond. G. Pascale” (Italy)</p><p>115 <italic>Novel HIV Vaccine Strategies</italic></p><p>Dan Barouch, MD, PhD</p><p>Director of the Centre for Virology and Vaccine Research in the Department of Medicine at Beth Israel Deaconess Medical Center (US)</p><p>116 <italic>Strategies and Mechanisms for Induction of Mucosal T Cell Immunity</italic></p><p>Jay A. Berzofsky, MD, PhD</p><p>Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute (US)</p><p>117 <italic>30 Years of HIV Vaccine Research</italic></p><p>José Esparza, MD, PhD</p><p>Senior Advisor on HIV Vaccines of the Bill and Melinda Gates Foundation (US)</p><p>118 <italic>The Dense Glycan Shield on the HIV Envelope: the Achilles Heel of the Virus?</italic></p><p>Jan Balzarini, MD, PhD</p><p>Laboratory of Virology and Chemotherapy, Rega Institute (Belgium)</p><p>119 <italic>The Anti-HIV Drug Pipeline</italic></p><p>John G. Bartlett, MD</p><p>Director, HIV Care Program, The Johns Hopkins Hospital (US)</p><p>120 <italic>Development of New HIV Inhibitors</italic></p><p>S.N.Kochetkov</p><p>Laboratory of Enzymology of Transcription, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences</p><p>121 <italic>Progress, Achievements and Challenges: a Review of China’s Free Antiretroviral Therapy Program</italic></p><p>Fujie Zhang, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>National Centre for AIDS/STD Control and Prevention (China)</p><p>122 <italic>Peptide Inhibitors of HIV</italic></p><p>Anders Vahlne, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>Karolinska Institute (Sweden)</p><p>123 <italic>New Antiretroviral Therapies</italic></p><p>James Rooney, MD</p><p>Vice President of Medical Affairs, Gilead Sciences, Inc. (US)</p><p>124 <italic>HIV Transmission and Pathogenesis in ex vivo Tissues</italic></p><p>Leonid Margolis, PhD<xref ref-type="fn" rid="fn1">*</xref></p><p>Head, Section of Intercellular Interactions, Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)</p><p>125 <italic>Progress toward a HIV cure</italic></p><p>Alain Lafeuillade, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>Department of Infectious Diseases, Toulon General Hospital (France)</p><p>126 <italic>Questions and challenges in HIV drug resistance: A molecular perspective</italic></p><p>Luis Menéndez-Arias, PhD<xref ref-type="fn" rid="fn1">*</xref></p><p>Centro de Biologia Molecular “Severo Ochoa” (CSIC-UAM), Madrid (Spain)</p><p>127 <italic>Safety, pharmokinetics and efficacy of VM-1500, a novel reverse transcriptase inhibitor, In healthy volunteers and HIV-infected patients</italic></p><p>Vadim Bichko, M.D.</p><p>Viriom Ltd. (Russia)</p><p>128 <italic>Cure of HBV infection: can APOBEC3 deaminases mediate it?</italic></p><p>Ulrike Protzer, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>Institute of Virology, TU Munich (Germany)</p><p>129 <italic>Polio Vaccines: The Past, Present and the Future</italic></p><p>Konstantin Chumakov, PhD<xref ref-type="fn" rid="fn1">*</xref></p><p>Chief of the Laboratory of Method Development, Division of Viral Products in the Food and Drug Administration (US)</p><p>130 <italic>HTLV-I and Adult T Cell Leukemia/Lymphoma (ATLL): Cellular and Molecular Basis of Transformation</italic></p><p>William Hall, MD</p><p>University College, Dublin (Ireland)</p><p>131 <italic>Replication and Assembly of Filoviruses</italic></p><p>Stephan Becker, PhD<xref ref-type="fn" rid="fn1">*</xref></p><p>Institute of Virology at the University of Marburg (Frankfurt, Germany)</p><p>132 <italic>A Novel Pathway of Proviral HIV-1 Latency Regulated by Aminoacid Starvation and HDAC-4</italic></p><p>Guide Poli, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>Head, AIDS Immunopathogenesis Unit, San Raffaele Scientific Institute (Italy)</p><p>133 <italic>Ebola virus matrix: structural transformation begets multiple structures in the virus life cycle</italic></p><p>Erica Ollmann Saphire, PhD<xref ref-type="fn" rid="fn1">*</xref></p><p>Department of Immunology and Microbial Science of the Scripps Research Institute (US)</p><p>134 <italic>Host Restriction of Schmallenberg Virus</italic></p><p>Massimo Palmarini, DVM, Ph.D., FRSE<xref ref-type="fn" rid="fn1">*</xref></p><p>Chair of Virology, University of Glasgow Centre for Virus Research (UK)</p><p>135 <italic>HIV-associated immunodeficiency despite potent antiretroviral therapy with CD4 T cell reconstitution</italic></p><p>C. David Pauza, PhD<xref ref-type="fn" rid="fn1">*</xref></p><p>Institute of Human Virology, University of Maryland School of Medicine (US)</p><p>136 <italic>HIV-1 Nef regulates activity of endoplasmic reticulum chaperone calnexin</italic></p><p>Michael Bukrinsky, MD, PhD</p><p>Department of Microbiology, Immunology and Tropical Medicine at the George, Washington University (US)</p><p>137 <italic>Interplay Between Host Defenses and Viral Anti-defenses: A Major Factor of Cytopathogenicity of Picornaviruses</italic></p><p>V.I.Agol, MD, PhD, DSc</p><p>M.P.Chumakov Institute of Poliomyelitis and Viral Encephalitis, Russian Academy of Medical Sciences (Russia)</p><p>138 <italic>Understanding protective immunity: Lessons from measles</italic></p><p>Diane Griffin MD, PhD<xref ref-type="fn" rid="fn1">*</xref></p><p>Alfred and Jill Sommer Professor, Chair of the Department of Molecular Microbiology and Immunology, the Johns Hopkins Bloomberg School of Public Health (US)</p><p>139 <italic>Dengue Vector Control: Critical Needs and Opportunities for Helping to Control the Dengue Pandemic</italic></p><p>Barry J. Beaty, PhD<xref ref-type="fn" rid="fn1">*</xref></p><p>University Distinguished Professor, Department of Microbiology, Immunology and Pathology, Colorado State University (US)</p><p>140 <italic>Reversing the Epidemic of HIV-1C in Southern Africa with Treatment as Prevention</italic></p><p>Myron Essex, DVM, PhD</p><p>Mary Woodard Lasker Professor of Health Sciences Harvard School of Public Health, Harvard University (US)</p><p>141 <italic>Gene Discovery and Data Sharing in Genome Wide Association Analyses: lessons from AIDS genetic restriction genes</italic></p><p>Steven O’Brien</p><p>St. Petersburg State University (Russia)</p><p>142 <italic>Sochi Virus as a Highly Pathogenic and Life-threatening Agent</italic></p><p>E.A.Tkachenko, MD, PhD, DSc</p><p>M.P. Chumakov Institute of Poliomyelitis and Viral Encephalitis, Russian Academy of Medical Sciences (Russia)</p><p>143 <italic>Rift Valley Fever Virus: a Virus with Potential for Global Emergence</italic></p><p>Janusz T. Paweska, DVSc, dr hab., Prof Vet. Sci.<xref ref-type="fn" rid="fn1">*</xref></p><p>Head, Centre for Emerging and Zoonotic Diseases, National Institute for Communicable Diseases National Health Laboratory Service (South African Republic)</p><p>144 <italic>Viral-Bacterial Mixed Infections Transmitted by Ticks: Diagnosis and Prevention in Russia</italic></p><p>E. I. Korenberg</p><p>Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Health Ministry of the Russian Federation</p><p>145 <italic>Arbovirus and Related Infectious Diseases in China</italic></p><p>Guodong Liang, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>National Institute for Viral disease Control and Prevention, China CDC (China)</p><p>146 <italic>Understanding the Pathogenesis of Prion and Surveillance for Human Prion Diseases in China</italic></p><p>Xiaoping Dong, PhD<xref ref-type="fn" rid="fn1">*</xref></p><p>National Institute for Viral Disease Control and Prevention, China CDC (China)</p><p>147 <italic>Globalization and New Challenges Caused of Communicable Diseases</italic></p><p>Saulius Chaplinskas, MD, PhD</p><p>Director, Center for Communicable Diseases and AIDS (Vilnus, Lithuania)</p><p>148 <italic>HPV, HIV, and Cancer: A Global Challenge</italic></p><p>Silvia Franceschi, MD</p><p>Special Advisor, Head, Infections and Cancer Epidemiology Group, International Agency for Research on Cancer (IARC) (Lyon, France)</p><p>149 <italic>HCV and Lymphoma</italic></p><p>Anna Linda Zignego, MD, PhD</p><p>Director, Interdepartmental Center MaSVE, Department of Experimental and Clinical Medicine, University of Florence (Italy)</p><p>150 <italic>Carcinogenesis of HPV</italic></p><p>Franco M. Buonaguro, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>Director, Molecular Biology and Viral Oncogenesis Unit, National Cancer Institute “Fondazione G. Pascale” (Naples. Italy)</p><p>151 <italic>Tumorigenic Polyoma Viruses</italic></p><p>Patrick Moore, MD, MPH<xref ref-type="fn" rid="fn1">*</xref></p><p>Professor, Department of Microbiology and Molecular Genetics, School of Medicine and Department of Infectious Diseases and Microbiology, University of Pittsburgh (US)</p><p>152 <italic>Insights into the pathogenesis of HHV8-driven body cavity lymphomas</italic></p><p>Luigi Chieco-Bianchi, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>Immunology and Molecular Oncology, Veneto Institute of Oncology, Dept of Surgery, Oncology & Gastroenterology, University of Padua (Italy)</p><p>153 <italic>Molecular Pathogenesis by HTLV-1 bZIP Factor</italic></p><p>Masao Matsuoka, MD, PhD</p><p>Institute for Virus Research, Kyoto University (Japan)</p><p>154 <italic>HIV and Cancer in Africa</italic></p><p>William A. Blattner, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>Professor and Associate Director, Institute of Human Virology, University of Maryland School of Medicine (US)</p><p>155 <italic>Evolution by Tumor Neofunctionalization and Phenomenon of Tumor Specifically Expressed, Evolutionarily Novel (TSEEN) Genes</italic></p><p>A. P. Kozlov</p><p>Professor and Director, Biomedical Center (St. Petersburg, Russia)</p><p>156 <italic>HIV and metabolic disease: Clues to control of HIV infection from the immune and viro logical response to high dose Vitamin D challenge</italic></p><p>Barry Peters, MBBS, DFFP, MD, FRCP</p><p>King’s College London (UK)</p><p>157 <italic>Pathogenesis of Epstein-Barr Virus-driven Lymphomas of HIV+ Patients: new insights of potential clinical relevance</italic></p><p>Riccardo Dolcetti, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>Head, Cancer Bio-Immunotherapy Unit, IRCCS—National Cancer Institute (Italy)</p><p>158 <italic>Hepatitis C Treatment Update: Current Status and Future Directions</italic></p><p>Shyam Kottilil, MD, PhD</p><p>National Institute of Allergy and Infectious Diseases (US)</p><p>159 <italic>Hepatitis B Treatment Update: Current Status and Future Directions</italic></p><p>Rohit Talwani, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>Institute of Human Virology, University of Maryland School of Medicine (US)</p><p>160 <italic>Treatment Strategies to Minimize the Impact of Antiretroviral Drug Toxicities</italic></p><p>Bruce Gilliam, MD<xref ref-type="fn" rid="fn1">*</xref></p><p>Institute of Human Virology, University of Maryland School of Medicine (US)</p><p>161 <italic>Anti-tuberculosis Treatment for HIV-positive Patients in Moscow</italic></p><p>E.M.Bogorodskaya, MD, PhD</p><p>Moscow City Research and Practical Centre for Tuberculosis Control (Russia)</p><p>162 <italic>Confronting Tuberculosis in an African Population with HIV</italic></p><p>Abubakar Mussa Maghimbi, MD, MMed</p><p>Institute of Human Virology (Dar es Salaam, Tanzania)</p><p>163 <italic>HIV and kidney function with a focus on traditional risk factors and role of TDF, PI and other medication</italic></p><p>Patrick Mallon, MD, PhD</p><p>Associate Dean for Research and Innovation, UCD School of Medicine and Medical Science (Ireland)</p><p>*Abstracts appear as provided by authors</p></body><back><fn-group><fn fn-type="other" id="fn1"><label>*</label><p>GVN Member</p></fn></fn-group></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Belgique/explor/OpenAccessBelV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000249 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000249 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Belgique
|area= OpenAccessBelV2
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.25. |  |